Ronnie Maxwell Lawrence
15Patents
4h-index
24Co-inventors
60Inventor score
Filing activity: Dec 17, 2001 → Nov 14, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6548523B2 | Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties | Chemistry; Metallurgy | 13 | Expired |
| US7425639B2 | Process | Chemistry; Metallurgy | 13 | Expired |
| US7709677B2 | Process of preparing arylethanoldiamines | Chemistry; Metallurgy | 13 | Active |
| US8796269B2 | Crystalline 2-(3,5-Bis(trifluoromethyl)phenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-((7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)pyridin-3-yl)-N,2-dimethyl-propanamide of the formula (I), their use in therapy, and process for the preparation of the same | Human Necessities | 6 | Active |
| US8093242B2 | Crystalline forms of a pyridine derivative | Human Necessities | 4 | Active |
| US11117855B2 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | Chemistry; Metallurgy | 2 | Active |
| US10988436B2 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | Chemistry; Metallurgy | 2 | Active |
| US11072577B2 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | Chemistry; Metallurgy | 2 | Active |
| US10870644B2 | Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation | Chemistry; Metallurgy | 1 | Active |
| US7557209B2 | Process for the preparation of (1S,4R)-cis-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol | Human Necessities | 1 | Expired |
| US10947184B2 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | General | 0 | Revoked |
| US11584741B2 | Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation | Chemistry; Metallurgy | 0 | Active |
| US12358862B2 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | Chemistry; Metallurgy | 0 | Active |
| US12109192B2 | Organic acid addition salts of S-pindolol | Human Necessities | 0 | Active |
| US12358861B2 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.